GJA1 and ischemia: As cardioprotective effects of Cx43 have been described in vivo [25] and in vitro [26], particularly in the context of ischemia, the slight increase in protein levels of Cx43 may be a sign of an early counter regulation in response to cardiomyocyte damage.